Skip to content

Study of Use of Synera for Pain During Local Skin Infiltration With Lidocaine Before Epidural Placement

Randomized Study of the Use of Synera for Pain Relief During Local Lidocaine Needle Skin Infiltration for Epidural Placement in Subjects Undergoing Elective Cesarean Section.

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01775605
Enrollment
0
Registered
2013-01-25
Start date
2013-11-30
Completion date
2014-11-30
Last updated
2015-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Pain

Keywords

Subject

Brief summary

Local infiltration with lidocaine prior to epidural placement for cesarean section, although brief, can be painful. This pain can lead to increased anxiety and distress, adversely affecting patient's overall experience. This study proposes to examine the application of Synera pain patch prior to lidocaine infiltration to reduce this pain and anxiety. The primary objective of this study is to determine the effect of the Synera on maternal experience during epidural placement. The efficacy of Synera pain patch in reducing subject pain during skin infiltration with lidocaine prior to epidural placement in subjects presenting for scheduled cesarean section will be assessed.

Interventions

DRUGSynera

Synera Pain Patch

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 years old; * Undergoing pre-scheduled cesarean section; * Expected singleton birth; * BMI \<=35kg.m-2;

Exclusion criteria

* Undergoing emergency cesarean section; * Complications during pregnancy; * History of hypersensitivity to study medication(lidocaine or tetracaine) or para-aminobenzoic acid; * Allergies to bird proteins, feathers, or egg products; or any other skin allergies; dermatitis an open wound at the patch site or a history of difficult epidural placement;

Design outcomes

Primary

MeasureTime frame
Rating of pain intensity upon lidocaine infiltration30 minutes (following patch placement , upon lidocaine infiltration)

Secondary

MeasureTime frame
Subject anxiety1 hour (Upon admission to surgical holding area and after epidural placement)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026